ADHD and autism evaluation marketing: diagnosis claims, online quizzes, telehealth and school evaluations

Families searching for an ADHD or autism evaluation for a child, and adults who suspect ADHD in themselves, are looking for something specific: a clinician who will take the question seriously, a realistic wait time, a clear price and an honest description of what the evaluation involves. Marketing for this service sits close to three risk areas at once: diagnosis claims that oversell what one visit or one questionnaire can do, ads that read as a promise of a prescription, and privacy around a mental health condition. This guide covers what the federal sources say about each of them and how to write pages, ads and intake flows that hold up.

Two related topics have their own guides and are not repeated here. Medication management, Google certification for prescription services, audience limits and the details of the in-person evaluation rule are in our guide to psychiatric practice marketing. Therapy services after an autism diagnosis are in our guide to ABA therapy marketing. Clinics that also offer neurofeedback or qEEG brain mapping can use our guide to neurofeedback and qEEG clinic marketing.

Screening in primary care, which comes before an evaluation, and early intervention referrals are covered in our guide to developmental and autism screening outreach.

What an evaluation is, in the CDC’s words

The strongest copy for an evaluation page describes the process honestly, and the CDC gives you the language. Its page on diagnosing ADHD says that deciding if a child has ADHD is a process with several steps, that there is no single test to diagnose ADHD, and that other problems such as sleep disorders, anxiety, depression and certain learning disabilities can have similar symptoms. It describes a medical exam including hearing and vision tests to rule out other problems, and gathering information from parents, teachers and other adults about the child’s behavior in different settings.

For autism, the CDC page on screening and diagnosis says diagnosing autism spectrum disorder can be difficult because there is no medical test, such as a blood test, to diagnose it, and that doctors look at the child’s developmental history and behavior. It separates three stages: developmental monitoring, developmental screening and a formal developmental evaluation done by one or more trained specialists, who may observe the child, give a structured test, ask the parents questions or ask them to fill out questionnaires.

Those sentences translate directly into a page structure. Say what happens before the visit (forms for parents and, with permission, teachers), what happens at the visit or visits, what the report contains, and what happens if the result is not ADHD or autism, or is something else as well. A family that reads this before booking is less likely to be surprised, and an evaluation described as a process is harder to misread as a quick yes.

Who may diagnose: set state by state

The CDC page says an ADHD diagnosis can be made by a mental health professional, like a psychologist or psychiatrist, or by a primary care provider, like a pediatrician. Its autism page names developmental pediatricians, child psychologists, speech-language pathologists and occupational therapists among the specialists who may take part in a formal evaluation. Which of those professionals may make and sign a diagnosis on their own, and which may only contribute to a team evaluation, is a question of state licensing law and scope of practice, set state by state.

On your website, name the credential of the person who will see the patient and what that person will provide. If your evaluation team includes clinicians whose role is to assess and report rather than diagnose, say so. Do not let a page imply that a diagnosis is made by someone who is not licensed to make it, and check with your licensing board before you advertise a service across state lines by telehealth, since the clinician’s license has to fit the state where the patient is.

Claims about speed, certainty and online quizzes

Federal advertising law covers what an evaluation page promises. 15 U.S.C. 45 prohibits unfair or deceptive acts or practices, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of services. The FTC Health Products Compliance Guidance says marketers should consider each ad as a whole and assess the net impression conveyed by all its elements, and that when an ad lends itself to more than one reasonable interpretation, the advertiser is responsible for substantiating each one.

Apply that to the phrases this market reaches for. A headline such as “Get diagnosed in one visit” conveys certainty about the outcome and the timeline, and the CDC describes a multi-step process. “Diagnosed in minutes” or “no waitlist, results today” raise the same problem. If your evaluation does take place in one long appointment, say what the appointment covers and that a diagnosis is one possible result, not the purpose of the booking.

Online quizzes and self-checks need the same care. A screening questionnaire can help someone decide whether to book, but the CDC says there is no single test for ADHD or autism. A quiz that ends with “You have ADHD” or “Your score shows autism” presents a screening result as a diagnosis. Label it as a screening questionnaire, say that it does not diagnose, and make the next step a conversation with a clinician, not a payment page.

Testimonials raise one more point. The FTC guidance says testimonials that report results more dramatic than users can generally expect are likely to be deceptive, and that a disclaimer of dramatic results does not cure the deception. A quote such as “I finally got my diagnosis and my life changed” is a story about an outcome. For patient stories, see our guide to testimonials and before and after photos; the HIPAA authorization rule is covered below.

Do not sell a prescription

ADHD evaluation ads sit next to medication, and this is where the risk is highest. Under 21 U.S.C. 829(e), no controlled substance that is a prescription drug may be delivered, distributed or dispensed by means of the Internet without a valid prescription, and a valid prescription is one issued for a legitimate medical purpose, in the course of professional practice, by a practitioner who has conducted at least one in-person medical evaluation, or a covering practitioner, subject to the telemedicine exceptions in the law.

The HHS page on prescribing controlled substances via telehealth, checked on October 30, 2026, says the DEA, jointly with HHS, has extended the full set of COVID-19 era telemedicine flexibilities for prescribing controlled medications through December 31, 2026. Under those flexibilities, a DEA-registered practitioner can prescribe a schedule II to V controlled substance by telemedicine without an in-person evaluation if the required conditions are met. What applies after that date depends on further federal action, so recheck the page before you publish or renew any telehealth evaluation campaign.

Whatever the date, the marketing rule for an evaluation practice does not change: the evaluation is the service, and treatment, if any, follows from the clinician’s judgment. Words such as “get your prescription”, “medication in 48 hours” or a medication name next to a booking button turn an evaluation ad into a prescription ad. Write “if treatment is appropriate, your clinician will discuss options with you, which may or may not include medication.”

Google’s ad rules point the same way. Its Healthcare and medicines policy says Google restricts the promotion of services related to the online prescribing, dispensing and sale of prescription drugs, that businesses subject to the policy include telemedicine providers, that advertisers must apply to serve ads for prescription drug services, and that Google restricts the use of prescription drug terms in ads, landing pages and keywords. An evaluation campaign that avoids prescription language in the ad and on the landing page is easier to keep in policy.

A federal case worth reading before you add tracking

On April 15, 2024, the FTC announced a proposed order against a telehealth firm offering online mental health services. According to the FTC, the complaint alleged that the company disclosed consumers’ sensitive health information to third parties for advertising by using or integrating tracking tools on its website or apps, broke its privacy promises, and misled consumers about its cancellation policies. The press release says the order had to be approved by the court before taking effect, and it describes a ban on using health information for advertising purposes, with limited exceptions set out in the order.

The lesson for an evaluation practice is concrete. An intake form that asks about attention, mood or a child’s development, a quiz result page, or a booking confirmation page with an analytics or ad pixel on it can send a mental health signal to a third party. Our guide to tracking pixels on practice websites covers how to audit those pages. If you sell evaluations on a subscription or package basis, our guide to membership and auto-renewal rules covers cancellation.

School evaluations: what families are entitled to

Parents of school-age children ask whether they need a private evaluation to get school support. Federal education rules give a practice a reason to answer carefully rather than to sell urgency. Under 34 CFR 300.301, either a parent or a public agency may request an initial evaluation to determine whether a child is a child with a disability, and the evaluation must be conducted within 60 days of receiving parental consent, or within the timeframe the state sets. Under 34 CFR 300.306, a group of qualified professionals and the parent decide eligibility, and the public agency gives the parent a copy of the evaluation report at no cost. Separately, 34 CFR 104.35 requires a federally funded public school program to evaluate a student who needs or is believed to need special education or related services before initial placement. The CDC ADHD page also tells parents they can contact the school system for a free evaluation for children 3 years or older, or an early intervention program for children under 3.

A private evaluation still has a role. Under 34 CFR 300.502(c), if a parent shares an evaluation obtained at private expense, the results must be considered by the public agency, if it meets agency criteria, in any decision about the child’s education. Considered is not the same as decided. A page that says “our report gets your child an IEP” or “schools must accept our diagnosis” overstates the rule. A fair line reads: “You can share our report with your child’s school, which must consider it if it meets the school’s criteria. The school team, with you, decides eligibility for special education.” Also tell parents that they can ask the school for its own evaluation at no cost.

Patient stories and privacy

A story about an adult’s ADHD diagnosis or a child’s autism evaluation reveals a mental health or developmental condition. Under 45 CFR 164.508(a)(3), a covered entity must obtain an authorization for any use or disclosure of protected health information for marketing, with narrow exceptions for face-to-face communications and promotional gifts of nominal value. For a child, the parent or guardian signs, and the child’s own view deserves respect even when the law does not require it. Do not use a child’s photo, school or first name in an ad, and do not reply to a public review in a way that confirms someone is a patient.

Keep evaluation intake to what the visit needs. A pre-visit form can ask about concerns and history once the patient or parent has booked through a secure channel; an ad landing page does not need it.

Pages and ads that work inside the rules

The evaluation page that converts is the one that answers the questions families ask before they call. Write sections on who the evaluation is for (children of which ages, teens, adults), who performs it and their credential, what happens before and during the visits, what the report includes and how long it takes to receive, whether you accept insurance or are self-pay with a stated price, and what happens next if a diagnosis is made or not made. For self-pay, our guide to good faith estimates covers the federal notice.

For search, separate the topics: one page for child ADHD evaluations, one for autism evaluations, one for adult ADHD evaluations, each with its own description of the process. Use plain terms families type, such as “ADHD testing for kids” or “autism evaluation for toddlers”, in headings that describe your actual service. Put 988 on pages for adults, since an adult looking for help with attention may also be in distress.

Illustration: two ways to advertise an adult ADHD evaluation

Illustration: [Practice name] runs an ad reading “ADHD diagnosis online in one visit. Start treatment this week.” The landing page opens with a five-question quiz that ends with “You likely have ADHD” and a booking button, and the confirmation page carries an advertising pixel. The ad promises an outcome and a timeline, implies treatment, presents a screening result as a diagnosis and sends a mental health signal to an ad platform.

Illustration: [Clinic name] runs an ad reading “Adult ADHD evaluations in [county], in person and by video. See what the evaluation involves.” The landing page names the clinician’s credential, describes the questionnaires, interview and report, states the price, says that the evaluation may or may not result in a diagnosis and that treatment options are discussed only if appropriate, labels its self-check as a screening tool that does not diagnose, and has no ad pixels on intake or booking pages.

Checklist

• Describe the evaluation as a process, using the CDC’s own steps.
• Name who performs and signs the evaluation, and confirm with your licensing board that scope fits, state by state.
• Remove “diagnosed in one visit”, “results today” and similar certainty claims.
• Label any quiz as a screening questionnaire that does not diagnose.
• Keep medication names and prescription promises out of ads and landing pages.
• Recheck the HHS telehealth prescribing page and its December 31, 2026 date before any telehealth campaign runs.
• Audit intake, quiz and booking pages for tracking pixels.
• Describe school evaluations accurately, including the family’s right to a school evaluation at no cost.
• Get a signed HIPAA authorization before any patient story, and never feature a child without it.
• Show 988 on adult evaluation pages.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For an evaluation practice, that means evaluation pages that describe the process, credential and price plainly, ad copy without prescription language, phone and chat scripts that explain the steps and the wait, and booking flows that keep mental health signals away from ad platforms. We do not decide who may diagnose or what your clinicians may prescribe; your licensing board and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• CDC: Diagnosing ADHD
• CDC: Screening for Autism Spectrum Disorder
• HHS: Prescribing controlled substances via telehealth
• 21 U.S.C. 829: Prescriptions
• Google Ads: Healthcare and medicines policy
• FTC: Health Products Compliance Guidance
• FTC press release, April 15, 2024: proposed order on a telehealth firm’s use of sensitive data
• 34 CFR 300.301: Initial evaluations
• 34 CFR 300.306: Determination of eligibility
• 34 CFR 300.502: Independent educational evaluation
• 34 CFR 104.35: Evaluation and placement
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 15 U.S.C. 45: Unfair methods of competition and unfair or deceptive acts or practices
• 15 U.S.C. 52: Dissemination of false advertisements

More in Mental and behavioral health marketing